388 related articles for article (PubMed ID: 26166587)
1. Lennox-Gastaut syndrome. Management update.
Al-Banji MH; Zahr DK; Jan MM
Neurosciences (Riyadh); 2015 Jul; 20(3):207-12. PubMed ID: 26166587
[TBL] [Abstract][Full Text] [Related]
2. Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review.
Samanta D
Epilepsy Behav; 2021 Jan; 114(Pt A):107612. PubMed ID: 33243685
[TBL] [Abstract][Full Text] [Related]
3. Lennox-Gastaut syndrome: a comprehensive review.
Asadi-Pooya AA
Neurol Sci; 2018 Mar; 39(3):403-414. PubMed ID: 29124439
[TBL] [Abstract][Full Text] [Related]
4. Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients.
Montouris G; Aboumatar S; Burdette D; Kothare S; Kuzniecky R; Rosenfeld W; Chung S
Epilepsy Behav; 2020 Sep; 110():107146. PubMed ID: 32563898
[TBL] [Abstract][Full Text] [Related]
5. The pharmacological management of Lennox-Gastaut syndrome and critical literature review.
Verrotti A; Striano P; Iapadre G; Zagaroli L; Bonanni P; Coppola G; Elia M; Mecarelli O; Franzoni E; Liso P; Vigevano F; Curatolo P
Seizure; 2018 Dec; 63():17-25. PubMed ID: 30391662
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome.
Montouris GD; Wheless JW; Glauser TA
Epilepsia; 2014 Sep; 55 Suppl 4():10-20. PubMed ID: 25284033
[TBL] [Abstract][Full Text] [Related]
7. Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.
Strzelczyk A; Schubert-Bast S
CNS Drugs; 2021 Jan; 35(1):61-83. PubMed ID: 33479851
[TBL] [Abstract][Full Text] [Related]
8. Ketogenic diet in patients with Lennox-Gastaut syndrome.
Caraballo RH; Fortini S; Fresler S; Armeno M; Ariela A; Cresta A; Mestre G; Escobal N
Seizure; 2014 Oct; 23(9):751-5. PubMed ID: 25011392
[TBL] [Abstract][Full Text] [Related]
9. Update on the management of Lennox-Gastaut syndrome.
VanStraten AF; Ng YT
Pediatr Neurol; 2012 Sep; 47(3):153-61. PubMed ID: 22883278
[TBL] [Abstract][Full Text] [Related]
10. Management of seizures in Lennox-Gastaut syndrome.
Crumrine PK
Paediatr Drugs; 2011 Apr; 13(2):107-18. PubMed ID: 21351810
[TBL] [Abstract][Full Text] [Related]
11. Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data.
Kothare S; Kluger G; Sachdeo R; Williams B; Olhaye O; Perdomo C; Bibbiani F
Seizure; 2017 Apr; 47():25-33. PubMed ID: 28284045
[TBL] [Abstract][Full Text] [Related]
12. Understanding Lennox-Gastaut syndrome: insights from focal epilepsy patients with Lennox-Gastaut features.
Dupont S; Banica-Wolters R; An-Gourfinkel I; Lambrecq V; Navarro V; Adam C; Nguyen-Michel VH
J Neurol; 2017 Jul; 264(7):1388-1396. PubMed ID: 28584915
[TBL] [Abstract][Full Text] [Related]
13. Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study.
Nikanorova M; Brandt C; Auvin S; McMurray R
Epilepsy Behav; 2017 Nov; 76():63-70. PubMed ID: 28927712
[TBL] [Abstract][Full Text] [Related]
14. Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
Sankar R; Chez M; Pina-Garza JE; Dixon-Salazar T; Flamini JR; Hyslop A; McGoldrick P; Millichap JJ; Resnick T; Rho JM; Wolf S
Seizure; 2023 Aug; 110():42-57. PubMed ID: 37321047
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognosis of patients with Lennox--Gastaut syndrome in recent decades.
Kim HJ; Kim HD; Lee JS; Heo K; Kim DS; Kang HC
Epilepsy Res; 2015 Feb; 110():10-9. PubMed ID: 25616450
[TBL] [Abstract][Full Text] [Related]
16. Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.
Striano P; McMurray R; Santamarina E; Falip M
Epileptic Disord; 2018 Feb; 20(1):13-29. PubMed ID: 29313492
[TBL] [Abstract][Full Text] [Related]
17. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome.
Besag FMC; Vasey MJ; Chin RFM
Expert Opin Pharmacother; 2023; 24(11):1249-1268. PubMed ID: 37212330
[TBL] [Abstract][Full Text] [Related]
19. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
Wheless JW; Isojarvi J; Lee D; Drummond R; Benbadis SR
Epilepsy Behav; 2014 Dec; 41():47-52. PubMed ID: 25282105
[TBL] [Abstract][Full Text] [Related]
20. Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan.
Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
Epilepsy Res; 2014 Nov; 108(9):1627-36. PubMed ID: 25219353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
